Tehmina Masud | Head of Translational Sciences
Nome Therapeutics
Tehmina Masud, MBBS PhD, is Chief Scientific Officer and Head of Translational Sciences at Nome Therapeutics, where she leads the development of AI-enabled pathways for N-of-1 genetic therapies. With more than 14 years applying AI insights across human genetics, drug discovery, and translational medicine, she brings a rare combination of clinical and scientific expertise to making individualized therapies scalable and sustainable.
Appearances:
Day 1 - World Orphan Drug Congress USA 2026 @ 12:00
Showcase 4: Stuck Below Scale: Building AI to Make N-of-1 Therapies Sustainable
last published: 09/Jun/26 18:45 GMT
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events